1. Home
  2. TWST vs CORT Comparison

TWST vs CORT Comparison

Compare TWST & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twist Bioscience Corporation

TWST

Twist Bioscience Corporation

N/A

Current Price

$154.09

Market Cap

9.2B

Sector

Health Care

ML Signal

N/A

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$81.34

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TWST
CORT
Founded
2013
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2B
9.7B
IPO Year
2018
2001

Fundamental Metrics

Financial Performance
Metric
TWST
CORT
Price
$154.09
$81.34
Analyst Decision
Buy
Buy
Analyst Count
13
5
Target Price
★ $168.25
$141.00
AVG Volume (30 Days)
★ 2.8M
830.8K
Earning Date
11-12-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 63.89
N/A
EPS
N/A
★ 0.09
Revenue
$376,572,000.00
★ $761,407,000.00
Revenue This Year
$21.17
$50.53
Revenue Next Year
$20.24
$46.23
P/E Ratio
★ N/A
$954.56
Revenue Growth
★ 20.32
12.79
52 Week Low
$23.30
$28.66
52 Week High
$219.71
$126.38

Technical Indicators

Market Signals
Indicator
TWST
CORT
Relative Strength Index (RSI) 49.20 22.77
Support Level $122.05 $77.38
Resistance Level $155.44 $122.93
Average True Range (ATR) 13.90 5.84
MACD 1.25 -3.55
Stochastic Oscillator 45.60 0.71

Price Performance

Historical Comparison
TWST
CORT

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: